• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Themis Medicare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis
  • BSE Code : 4895.0
  • ISIN : INE083B01024
105.21 -2 (-2.12%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    103.07
  • Today’s High

    111.00
  • Open

    107.11
  • Perv Close

    107.49
  • 52W Low

    103.07
  • 52W High

    317.00

Key Indicators

  • P/E(TTM)

    40.40

  • Mar.Cap (₹Cr.)

    968.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    31.17

  • Debt-Equity Ratio

    -2.12

  • AGM Date

    01-Aug-2025

  • EPS

    2.60

  • P/E Ratio

    40.40

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    968.35

  • RONW (%)

    13.39

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    9.20

  • BV (₹)

    31.20

  • Sales( ₹ in Cr.)

    405.51

  • NP (in Cr.)

    23.92

  • NP Var(%)

    -3.0

  • Div%

    0.0

  • CPS (₹)

    3.70

  • EPS (₹)

    2.60

  • Traded Value (₹ in Lakhs)

    966.88

  • 52 Week High

    317.00

  • 52 Week Low

    103.07

  • Price BSE

    105.0

  • Price NSE

    105.00

  • Market Capital( in Cr.)

    966.88

  • P/C Ratio

    28.50

  • P/E Ratio

    40.40

  • Price Vs.BV

    2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 381.76 354.32 394.61 230.67 201.59 184.11
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 381.76 354.32 394.61 230.67 201.59 184.11
Other Income 4.76 11.50 6.54 3.62 3.47 2.69
Stock Adjustments 1.57 7.79 -3.06 1.27 3.49 0.22
Total Income 388.09 373.61 398.09 235.56 208.55 187.02
EXPENDITURE :            
Raw Materials 138.28 126.16 145.08 79.48 66.67 68.81
Power and Fuel Cost 13.46 11.83 12.18 11.32 11.49 9.70
Employee Cost 82.41 66.15 51.97 39.99 44.28 45.64
Other Manufacturing Expenses 27.52 25.98 32.96 16.11 16.93 17.45
Selling and Administration Expenses 51.84 44.15 34.85 21.00 22.17 30.67
Miscellaneous Expenses 18.29 20.39 18.86 14.16 7.86 9.48
Employee Benefit Expenses 82.41 66.15 51.97 39.99 44.28 45.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 331.79 294.66 295.90 182.06 169.39 181.76
Operating Profit 56.29 78.96 102.19 53.50 39.15 5.26
Interest 9.38 9.56 8.77 12.71 12.88 11.82
Gross Profit 46.91 69.40 93.42 40.79 26.27 -6.56
Depreciation 12.25 10.49 9.48 8.55 8.27 7.98
Profit Before Tax 34.66 58.91 83.94 32.24 18.00 -14.54
Current Tax 9.22 15.00 16.75 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.70 0.61 5.63 5.63 2.09 -1.84
Reported Net Profit 24.75 43.29 61.56 26.62 15.91 -12.70
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 24.75 43.29 61.56 26.62 15.91 -12.70
Adjustment below Net Profit -0.74 -0.43 -0.32 1.46 -0.17 -0.05
P & L Balance brought forward 135.62 96.79 38.98 11.98 -4.27 8.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.14 4.03 3.43 1.09 -0.51 -0.40
P & L Balance carried down 155.50 135.62 96.79 38.98 11.98 -4.27
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 43.00 17.50 0.00
Dividend Per Share(Rs) 0.50 5.00 5.00 4.30 1.75 0.00
Earnings Per Share-Unit Curr 2.69 47.04 66.91 28.97 17.32 0.00
Earnings Per Share(Adj)-Unit Curr 2.69 4.70 6.69 2.90 1.73 0.00
Book Value 29.11 269.54 227.50 164.59 135.33 117.60
Book Value(Adj)-Unit Curr 29.11 26.96 22.75 16.46 13.53 11.76

Shareholding Pattern

  • Promoter Group

    67.15%

  • Public Share Holding

    32.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,843,080 9.61 8,843,080 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,843,080 9.61 8,843,080 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 24,429,460 26.54 24,429,460 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 28,531,450 31.00 28,531,450 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 52,960,910 57.54 52,960,910 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10,000 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,317 0.00 4,317 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 85,476 0.09 85,476 11
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,101 0.00 1,101 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 950 0.00 950 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 101,844 0.11 91,844 18
2] Non Institution
Bodies Corporate 2,970,387 3.23 2,969,387 130
Clearing Members 1,100 0.00 1,100 1
Directors of their Relatives 70,500 0.08 70,500 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,819,138 3.06 2,618,138 311
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,525,948 1.66 1,524,808 561
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,669,343 7.25 6,669,343 9
Individuals holding nominal share capital up to Rs. 1 lakh 15,552,115 16.90 14,931,355 18,271
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 367,840 0.40 367,840 2
Sub Total 30,134,286 32.74 29,310,386 19,304
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,040,120 100.00 91,206,220 19,335

Company Background

Themis Medicare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis Medicare Ltd
  • BSE Code : 4895.0
  • ISIN : INE083B01024
  • Incorporation Year

    1969

  • Registered Office

    Plot No 69 A GIDC Indl Estate
    Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-260-2421675

  • FAX

    91-260-2430219

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

    Pradeep Chandan.

  • Auditor

    Krishaan & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Themis Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Themis Medicare 105.05 386.52 381.76 40.40 12.51
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10